CD163 and neoplasm: Colabeling of Iba1 with proposed TAM-specific markers CD14 and CD163 revealed a subset of both Iba1+ CD14+ or CD163+ and Iba1+ CD14− or CD163− cells in both tumor and epilepsy tissue (Figure 2C and D, G and H).